Home › RegulatoryAnika Therapeutics, Inc. - 10-Q FilingAnika Therapeutics reports Q3 2026 financial results for period ended September 30, 2026SEC EDGAR · November 6, 2026, 19:51 UTCTickers: $ANIK Read the full article at SEC EDGAR